DSM Firmenich AG (DSFIR)

Currency in EUR
112.70
+5.30(+4.93%)
Real-time Data·
Advertisement
Trading near 52-week High
DSFIR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
108.60113.45
52 wk Range
55.22113.45
Key Statistics
Prev. Close
107.4
Open
108.75
Day's Range
108.6-113.45
52 wk Range
55.22-113.45
Volume
386.63K
Average Volume (3m)
633.79K
1-Year Change
60.7194%
Book Value / Share
72.02
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DSFIR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
97.37
Downside
-13.60%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

DSM Firmenich AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

9 Buy
10 Hold
1 Sell
Ratings:
20 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 97.37
(-13.60% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Buy125.00+10.67%104.00Maintain05/11/2026
Barclays
Hold105.00-7.04%98.00Maintain05/11/2026
Morgan Stanley
Hold100.00-11.47%93.00Maintain05/11/2026
JPMorgan
Sell75.00-33.60%68.00Maintain05/11/2026
Barclays
Hold98.00-13.24%92.00Maintain30/09/2026

DSM Firmenich AG Earnings Call Summary for Q3/2026

  • DSM-Firmenich reported Q3 organic sales growth of 5% with EBITDA margin expanding to 20.4% from 19.5% in Q2, driven by strong fragrance demand.
  • Perfumery & Beauty led with 8% organic growth; Health, Nutrition & Care rose 5% on HMO products; Taste, Texture & Health grew 3-4% despite North America softness.
  • Management raised 2025 organic sales outlook and reaffirmed 2026-2027 targets: 4-6% growth, 21% EBITDA margin by 2027, EUR 50M restructuring savings.
  • Stock declined 1.23% to $104.35, near 52-week high; company expects 3% raw material inflation in 2027, manageable through pricing and cost discipline.
  • CEO De Vreeze emphasized consistent execution; CFO Schmeitz confirmed full-year cash conversion target of 11-12%; no customer destocking observed in quarter.
Last Updated: 04/11/2026, 09:10
Read Full Transcript

Earnings

Latest Release
04/11/2026
EPS / Forecast
0.93 / 0.98
Revenue / Forecast
2.37B / 2.33B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.28
Dividend Yield
2.33%
Industry Median 2.36%
Annualised payout
2.50
Paid unevenly
5-Years Growth
+0.82%
Growth Streak

Compare DSFIR to Peers and Sector

Metrics to compare
DSFIR
Peers
Sector
Relationship
P/E Ratio
81.9x24.4x3.6x
PEG Ratio
−0.260.040.00
Price/Book
1.5x2.2x1.6x
Price / LTM Sales
2.9x1.7x1.2x
Upside (Analyst Target)
−13.7%4.2%49.4%
Fair Value Upside
Unlock4.4%4.8%Unlock

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. DSM-Firmenich AG was founded in 1902 and is based in Kaiseraugst, Switzerland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
82.75M33.50%8.89B
Other Institutional Investors
9.05M3.66%971.86M
Public Companies & Retail Investors
155.21M62.83%16.67B
Total
247.01M100.00%26.53B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Artisan Partners Funds, Inc. - Artisan International Value Fund6.83%16,878,4441,812,745
Artisan Partners Limited Partnership6.53%16,126,0331,731,936

People Also Watch

104.00
IMCD
-0.48%
33.85
FASTN
-1.17%
32.94
SBMO
-0.06%
41.04
AALB
-1.91%
53.00
RECI
-0.19%

FAQ

What Is the DSM Firmenich (Amsterdam: DSFIR) Share Price Today?

The DSM Firmenich stock price today is 112.70 EUR.

What Stock Exchange Does DSM Firmenich (DSFIR) Trade On?

DSM Firmenich is listed and trades on the Amsterdam Stock Exchange.

What Is the Ticker (Stock Symbol) for DSM Firmenich?

The stock symbol (also called a 'ticker') for DSM Firmenich is "DSFIR."

Does DSM Firmenich Pay Dividends? What’s The Current DSFIR Dividend Yield?

Yes, DSFIR Pays Dividends to its Shareholders. The current DSM Firmenich dividend yield is 2.3%%.

What Is the Current DSM Firmenich Market Capitalisation?

As of today, DSM Firmenich (Amsterdam: DSFIR) market cap is 26.53B EUR.

What Is DSM Firmenich's (DSFIR) Earnings Per Share (TTM)?

The DSM Firmenich EPS is currently 1.28 (Trailing Twelve Months).

When Is the Next DSM Firmenich Earnings Date?

DSM Firmenich's next earnings report will be released on 18/02/2027.

Is DSFIR a Buy or Sell From a Technical Analyst Perspective?

Based on today's DSM Firmenich moving averages and other technical indicators, the daily buy/sell signal for DSFIR stock is Strong Buy.

How Many Times Has DSM Firmenich Stock Split?

DSM Firmenich has split 0 times. (See the DSFIR stock split history page for full effective split date and price information.)

How Many Employees Does DSM Firmenich Have?

DSM Firmenich has 20786 employees, based on their latest Companies House report.

What is the current trading status of DSM Firmenich (Amsterdam: DSFIR)?

As of 05/11/2026, DSM Firmenich (DSFIR) is trading at a share price of 112.70 EUR, with a previous close of 107.40 EUR. The stock has fluctuated within a day range of 108.60 EUR to 113.45 EUR, while its 52-week range spans from 55.22 EUR to 113.45 EUR.

What Is DSM Firmenich (DSFIR) Price Target According to Analysts?

The average 12-month price target for DSM Firmenich is 97.37 EUR, with a high estimate of 117 EUR and a low estimate of 68 EUR. 9 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -13.60% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.